Trial Profile
RECORD 1 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE, Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jan 2022
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis; Pulmonary embolism
- Focus Registrational; Therapeutic Use
- Acronyms RECORD-1
- Sponsors Bayer
- 12 Dec 2017 Results of exposure response analysis using patient data from RECORD-1, RECORD-2, RECORD-3 trials presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
- 18 Jan 2016 Retrospective analysis results published in the Annals of Pharmacotherapy
- 06 Nov 2012 Planned number of patients changed from 4000 to 4200 as reported by European Clinical Trials Database.